HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$0.60
Day range
$0.60 - $0.61
Year range
$0.28 - $2.60
Market cap
20.15M USD
Avg Volume
423.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 130.00K | 54.76% |
Operating expense | — | — |
Net income | — | — |
Net profit margin | -3.72K | 74.00% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -39.36% | — |
Return on capital | -43.60% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2003
Headquarters
Website
Employees
13
